Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Lack of Association Between CTLA-4 Genetic Polymorphisms and Noncardiac Gastric Cancer in a Chinese Population.

Liu J, Tang W, Lin W, Wang Y, Chen Y, Wang J, Liu M, Xu W, Lin J, Zhang L.

DNA Cell Biol. 2019 Mar 19. doi: 10.1089/dna.2018.4555. [Epub ahead of print]


Investigation of Cytotoxic T-lymphocyte antigen-4 polymorphisms in non-small cell lung cancer: a case-control study.

Chen S, Wang Y, Chen Y, Lin J, Liu C, Kang M, Tang W.

Oncotarget. 2017 Sep 4;8(44):76634-76643. doi: 10.18632/oncotarget.20638. eCollection 2017 Sep 29.


Investigation of Cytotoxic T-lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma.

Tang W, Wang Y, Chen S, Lin J, Chen B, Yu S, Chen Y, Gu H, Kang M.

Scand J Immunol. 2016 Mar;83(3):212-8. doi: 10.1111/sji.12409.


CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.

Qin XY, Lu J, Li GX, Wen L, Liu Y, Xu LP, Chang YJ, Liu KY, Jiang ZF, Huang XJ.

Ann Hematol. 2018 Mar;97(3):485-495. doi: 10.1007/s00277-017-3203-7. Epub 2017 Dec 21.


Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.

Guo Y, Gao J, Gao S, Shang M, Guo F.

Oncotarget. 2016 Apr 26;7(17):23088-95. doi: 10.18632/oncotarget.8714.


CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China.

Liu CP, Jiang JA, Wang T, Liu XM, Gao L, Zhu RR, Shen Y, Wu M, Xu T, Zhang XG.

Genet Mol Res. 2013 Apr 25;12(2):1373-82. doi: 10.4238/2013.April.25.8.


HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China.

Xiao W, Zhang Q, Deng XZ, Jiang LF, Zhu DY, Pei JP, Ge CY, Li BJ, Wang CJ, Zhang JH, Zhou ZX, Ding WL, Xu XD, Yue M.

Infect Genet Evol. 2015 Aug;34:52-60. doi: 10.1016/j.meegid.2015.06.016. Epub 2015 Jun 12.


Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves' disease in a Chinese Han population.

Chen X, Hu Z, Liu M, Li H, Liang C, Li W, Bao L, Chen M, Wu G.

BMC Med Genet. 2018 Sep 17;19(1):171. doi: 10.1186/s12881-018-0665-y.


Association between cytotoxic T-lymphocyte antigen 4 gene polymorphisms and primary biliary cirrhosis in Chinese population: data from a multicenter study.

Li Q, Wang B, Pan F, Zhang R, Xiao L, Guo H, Ma S, Zhou C.

J Gastroenterol Hepatol. 2013 Aug;28(8):1397-402. doi: 10.1111/jgh.12165.


Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.

Fang M, Huang W, Mo D, Zhao W, Huang R.

Cell Physiol Biochem. 2018;47(1):414-427. doi: 10.1159/000489953. Epub 2018 May 18.


Two genetic variants in prostate stem cell antigen and gastric cancer susceptibility in a Chinese population.

Wu C, Wang G, Yang M, Huang L, Yu D, Tan W, Lin D.

Mol Carcinog. 2009 Dec;48(12):1131-8. doi: 10.1002/mc.20565.


CTLA-4 confers a risk of recurrent schizophrenia, major depressive disorder and bipolar disorder in the Chinese Han population.

Liu J, Li J, Li T, Wang T, Li Y, Zeng Z, Li Z, Chen P, Hu Z, Zheng L, Ji J, Lin H, Feng G, Shi Y.

Brain Behav Immun. 2011 Mar;25(3):429-33. doi: 10.1016/j.bbi.2010.10.024. Epub 2010 Oct 30.


Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.

Misra MK, Kapoor R, Pandey SK, Sharma RK, Agrawal S.

J Interferon Cytokine Res. 2014 Mar;34(3):148-61. doi: 10.1089/jir.2013.0069. Epub 2013 Dec 7.


Cytotoxic T-lymphocyte antigen-4 genetic variants and risk of Ewing's sarcoma.

Feng D, Yang X, Li S, Liu T, Wu Z, Song Y, Wang J, Gao W, Huang Q, Huang W, Zheng W, Xiao J.

Genet Test Mol Biomarkers. 2013 Jun;17(6):458-63. doi: 10.1089/gtmb.2012.0488. Epub 2013 Mar 12.


Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.

Abtahi S, Izadi Jahromi F, Dabbaghmanesh MH, Malekzadeh M, Ghaderi A.

Endocrine. 2018 Oct;62(1):159-165. doi: 10.1007/s12020-018-1663-8. Epub 2018 Aug 4.


CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers.

Hadinia A, Hossieni SV, Erfani N, Saberi-Firozi M, Fattahi MJ, Ghaderi A.

J Gastroenterol Hepatol. 2007 Dec;22(12):2283-7.


The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.

Torres-Carrillo N, Ontiveros-Mercado H, Torres-Carrillo NM, Parra-Rojas I, Rangel-Villalobos H, Ramírez-Dueñas MG, Gutiérrez-Ureña SR, Valle Y, Muñoz-Valle JF.

Cell Biochem Biophys. 2013;67(3):1217-28. doi: 10.1007/s12013-013-9640-6.


CTLA-4 polymorphisms associate with breast cancer susceptibility in Asians: a meta-analysis.

Dai Z, Tian T, Wang M, Liu X, Lin S, Yang P, Liu K, Zheng Y, Xu P, Liu M, Yang X, Dai Z.

PeerJ. 2017 Jan 10;5:e2815. doi: 10.7717/peerj.2815. eCollection 2017.


A pilot study on cytotoxic T lymphocyte-4 gene polymorphisms in urinary schistosomiasis.

Idris ZM, Yazdanbakhsh M, Adegnika AA, Lell B, Issifou S, Noordin R.

Genet Test Mol Biomarkers. 2012 Jun;16(6):488-92. doi: 10.1089/gtmb.2011.0209. Epub 2012 Jan 30.


Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population.

Wang L, Li D, Fu Z, Li H, Jiang W, Li D.

BMC Cancer. 2007 Sep 10;7:173.

Supplemental Content

Support Center